Emergency Savings: What You Need for Life’s “What If’s”
Emergency Savings
What You Need for Life's "What If's"
by Alacias Enger
Living with HIV, Paula is a longtime A&U reader who works as a freelancer and...
Trump Strives to End HIV, But at Whose Expense?
A Plan for America
The Trump administration strives to end the HIV epidemic, but at whose expense?
by Jeannie Wraight
In this month’s Destination: Cure I’m going...
A Healthier Healthcare System: Interview with Charles Skiba, MD
A Healthier System
Dr. Charles Skiba, Jr., shares his plan
by Mark Rebernik
The raucous debate over healthcare reform has faded, along with any hope of a...
“Religious Objection” Rule
"Religious Objection" Rule
In a move that many health care providers and LGBTQ activists have condemned as an assault on LGBTQ access to health care,...
Automated Access to Safe Syringes
Vending Machines on a Mission
Las Vegas rolls out a tried and true harm reduction initiative
by Connie Rose
Harm reduction materials, safe sex items, pregnancy tests,...
An HIV Injectable Regimen Comes of Age
Without the Pill Box?
The First Long-Acting Injectable Regimen for Individuals Living with HIV Comes of Age
by Mel Baker
A funny thing happened on the way to...
Final Results of the PARTNER2 Study Confirm: U=U
Final Results of the PARTNER2 Study Confirm: U=U
Eight years, 1,000 serodiscordant gay male couples, and zero HIV transmissions
by Hank Trout
The final results of the...
CDC Recommends Measles Vaccination for PLHIV
CDC Recommends Measles Vaccination for PLHIV
Born after 1956? You probably do not have immunity to measles.
Twenty-five years after we thought we had eradicated measles...
JAK Inhibitors
JAK of All Trades
Researchers look to JAK inhibitors as part of hiv treatment & eradication
by Jeannie Wraight
R research on three Janus kinase inhibitors (JAK...
Slaying the Debt Dragon
Slaying the Debt Dragon
Positive reinforcement is the first step
by Alacias Enger
According to a 2017 survey by Career Builder, nearly 3 in 4 workers claim...
LATEST POSTS
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...
